[Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl)].
D002207:Capreomycin / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005860:Germany, West; D006801:Humans; D008826:Microbial Sensitivity Tests; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors; D014401:Tuberculosis, Urogenital / Q000188:drug therapy* / Q000382:microbiology
D002207:Capreomycin; D004977:Ethambutol; D012293:Rifampin